EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeit

Curcumin Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease: Mechanism Exploration, Clinical Application Strategies, and Application Limitations Challenges

Siyu Lan, Xinyi Zhou, Yifei Xiang, Yan Huang, Chaolong Rao iD

Phytotherapy Research · 2026-07 · 40 (7) · 4254-4277

DOI: 10.1002/ptr.70361 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Phytotherapy Research, online erschienen am 30.04.2026. Verfasst von Siyu Lan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Curcumin, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 168 Literaturangaben. Gefördert von: The Sichuan Provincial Administration of Traditional Chinese Medicine, Sichuan Provincial Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction‐associated steatotic liver disease (MASLD), as a liver phenotype of metabolic syndrome, has a global prevalence of up to 32.4%. Its pathogenesis involves complex pathological networks, including lipid metabolism disorders, oxidative stress, inflammation, and insulin resistance. Faced with the limitations of existing single‐target drugs, curcumin, a natural polyphenolic compound, has demonstrated significant potential for the prevention and treatment of MASLD due to its multidimensional pharmacological activities, such as antioxidant, anti‐inflammatory, metabolic regulation, and mitochondrial function repair. This article provides a systematic review of recent research on curcumin therapeutic mechanisms and clinical evidence in MASLD, with a focus on its antioxidant effect, improvement of mitochondrial function, anti‐inflammatory effect, reduction of insulin resistance, and regulation of gut microbiota. It also examines the current efficacy and limitations of curcumin‐based combination therapies and their derivatives in the treatment of MASLD. As research on MASLD progresses, curcumin shows great potential for therapeutic applications. Future studies should target long‐term impacts, such as subclinical oxidative stress and epigenetic modifications. Furthermore, this article addresses persistent challenges such as curcumin's inherently low bioavailability and the lack of standardized dosing protocols, which should guide future clinical research efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminNon-alcoholic Fatty Liver DiseaseFatty LiverHumansAntioxidantsOxidative StressAnimalsInsulin ResistanceAnti-Inflammatory AgentsMetabolic Syndrome

Stichwörter der Autor:innen

MASLDNAFLDbioavailabilityclinical application strategycurcuminmechanism

Substanzen

CurcuminAntioxidantsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • R&D Center for Efficiency, Safety and Application in Chinese Materia Medica With Medical and Edible Values, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

ORCID-Profile: Chaolong Rao

Förderung

  • The Sichuan Provincial Administration of Traditional Chinese Medicine
  • Sichuan Provincial Administration of Traditional Chinese Medicine

Zitieren

APA

Lan, S., Zhou, X., Xiang, Y., Huang, Y., & Rao, C. (2026). Curcumin Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease: Mechanism Exploration, Clinical Application Strategies, and Application Limitations Challenges. Phytotherapy Research, 40(7), 4254-4277. https://doi.org/10.1002/ptr.70361

Vancouver

Lan S, Zhou X, Xiang Y, Huang Y, Rao C. Curcumin Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease: Mechanism Exploration, Clinical Application Strategies, and Application Limitations Challenges. Phytotherapy Research. 2026;40(7):4254-4277. doi:10.1002/ptr.70361

BibTeX
@article{Lan2026,
  author = {Lan, Siyu and Zhou, Xinyi and Xiang, Yifei and Huang, Yan and Rao, Chaolong},
  title = {Curcumin Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease: Mechanism Exploration, Clinical Application Strategies, and Application Limitations Challenges},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {7},
  pages = {4254--4277},
  doi = {10.1002/ptr.70361}
}
Kostenlos starten →